09:51 AM EST - Acerus Pharmaceuticals Corporation : Confirmed that it has been served with a statement of claim filed in the Ontario Superior Court of Justice by Eugene Melnyk against the company, as well as its Chairman and President & Chief Executive Officer. Acerus firmly believes that the entirety of the allegations is without merit from a factual or legal basis, and maintains its position regarding the appropriate conduct of the business and its management. In particular, the company believes that the claims relating to alleged improper related party and non-arm’s length transactions are entirely baseless and without support. The company, and the other named co-defendants, intend to vigorously defend against the claims and will pursue all other potential legal actions as next steps. Acerus Pharmaceuticals Corporation
shares T.ASP are trading unchanged at $0.16.
